Marrone Bio Innov (MBII)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 12-2020 | 09-2020 | 06-2020 | 03-2020 | 12-2019 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -20,168 | -15,957 | -9,894 | -7,024 | -37,175 |
| Depreciation Amortization | 4,365 | 3,256 | 2,175 | 1,097 | 3,154 |
| Accounts receivable | -4,188 | -902 | -5,512 | -4,492 | -2,622 |
| Accounts payable and accrued liabilities | -1,409 | -1,337 | -2,272 | 3,068 | 1,204 |
| Other Working Capital | -5,737 | -879 | -2,991 | -2,550 | 769 |
| Other Operating Activity | 11,178 | 7,219 | 10,752 | 3,609 | 13,331 |
| Operating Cash Flow | $-15,959 | $-8,600 | $-7,742 | $-6,292 | $-21,339 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -557 | -456 | -401 | -133 | -944 |
| Net Acquisitions | N/A | N/A | N/A | N/A | -5,849 |
| Other Investing Activity | -1,240 | -890 | -890 | -540 | 0 |
| Investing Cash Flow | $-1,797 | $-1,346 | $-1,291 | $-673 | $-6,793 |
| Cash Flows From Financing Activities | |||||
| Debt Issued | 40,329 | 32,837 | 24,724 | 11,319 | 29,517 |
| Debt Repayment | -35,314 | -30,898 | -20,115 | -6,518 | -29,537 |
| Common Stock Issued | 22,434 | 10,759 | 8,673 | 6,096 | 16,183 |
| Common Stock Repurchased | N/A | 31 | 14 | N/A | N/A |
| Other Financing Activity | -104 | -64 | -64 | -64 | 0 |
| Financing Cash Flow | $27,345 | $12,665 | $13,232 | $10,833 | $16,163 |
| Beginning Cash Position | 7,812 | 7,812 | 7,812 | 7,812 | 19,781 |
| End Cash Position | 17,401 | 10,531 | 12,011 | 11,680 | 7,812 |
| Net Cash Flow | $9,589 | $2,719 | $4,199 | $3,868 | $-11,969 |
| Free Cash Flow | |||||
| Operating Cash Flow | -15,959 | -8,600 | -7,742 | -6,292 | -21,339 |
| Capital Expenditure | -559 | -458 | -403 | -135 | -965 |
| Free Cash Flow | -16,518 | -9,058 | -8,145 | -6,427 | -22,304 |